LabCorp Posts 2 Percent Revenue Growth in Q4 but Misses Estimates | GenomeWeb

NEW YORK (GenomeWeb News) – Laboratory Corporation of America today reported fourth quarter revenue growth of around 2 percent, but it fell short of Wall Street estimates on the top and bottom line.

The clinical lab giant reported total revenues of $1.44 billion for the three months ended Dec. 31, up from $1.41 billion for the fourth quarter of 2012 but below the average analyst estimate of $1.45 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.